Literature DB >> 29377165

Pathophysiological mechanisms of autoimmunity.

Muriel Sudres1,2,3, Julien Verdier1,2,3, Frédérique Truffault1,2,3, Rozen Le Panse1,2,3, Sonia Berrih-Aknin1,2,3.   

Abstract

Autoimmune diseases (AIDs) are chronic disorders characterized by inflammatory reactions against self-antigens that can be either systemic or organ specific. AIDs can differ in their epidemiologic features and clinical presentations, yet all share a remarkable complexity. AIDs result from an interplay of genetic and epigenetic factors with environmental components that are associated with imbalances in the immune system. Many of the pathogenic mechanisms of AIDs are also implicated in myasthenia gravis (MG), an AID in which inflammation of the thymus leads to a neuromuscular disorder. Our goal here is to highlight the similarities and differences between MG and other AIDs by reviewing the common transcriptome signatures and the development of germinal centers and by discussing some unresolved questions about autoimmune mechanisms. This review will propose hypotheses to explain the origin of regulatory T (Treg ) cell defects and the causes of chronicity and specificity of AIDs.
© 2018 New York Academy of Sciences.

Entities:  

Keywords:  Treg cells; chronicity; genetics; germinal centers; inflammation; triggering factors

Mesh:

Year:  2018        PMID: 29377165     DOI: 10.1111/nyas.13560

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Observation on the efficacy of different methylprednisolone regimens in the treatment of myasthenia gravis.

Authors:  Xiaoting Lin; Guoyan Qi
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

Review 2.  Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.

Authors:  Inga Koneczny; Ruth Herbst
Journal:  Cells       Date:  2019-07-02       Impact factor: 6.600

Review 3.  Thymus and autoimmunity.

Authors:  Alexander Marx; Yosuke Yamada; Katja Simon-Keller; Berthold Schalke; Nick Willcox; Philipp Ströbel; Cleo-Aron Weis
Journal:  Semin Immunopathol       Date:  2021-02-03       Impact factor: 9.623

Review 4.  Immunomodulatory Effects of Dietary Polyphenols.

Authors:  Hira Shakoor; Jack Feehan; Vasso Apostolopoulos; Carine Platat; Ayesha Salem Al Dhaheri; Habiba I Ali; Leila Cheikh Ismail; Marijan Bosevski; Lily Stojanovska
Journal:  Nutrients       Date:  2021-02-25       Impact factor: 5.717

Review 5.  The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes.

Authors:  Valeria Caneparo; Santo Landolfo; Marisa Gariglio; Marco De Andrea
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

6.  Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.

Authors:  Masaharu Takamori
Journal:  Front Mol Neurosci       Date:  2020-05-28       Impact factor: 5.639

Review 7.  Recent Advances on the Anti-Inflammatory and Antioxidant Properties of Red Grape Polyphenols: In Vitro and In Vivo Studies.

Authors:  Thea Magrone; Manrico Magrone; Matteo Antonio Russo; Emilio Jirillo
Journal:  Antioxidants (Basel)       Date:  2019-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.